SKYRIZI sol inj 75 mg/0.83ml ser pré 2 pce
7680669440015
CH-66944
L04AC18
07.15.0.
Reimbursement limitations:
SKYRIZI.01
Formes sévères de psoriasis en plaque (seulement dosage à 150 mg)
La prescription médicale ne …
1 / 3
google
Details
- Product number
- 6694401
- CPT
- -
- Packaging group
- 2
- Unit
- Fertigspritze(n)
- Composition
- Lösung: risankizumabum 75.0 mg, sorbitolum 34 mg, dinatrii succinas hexahydricus corresp. natrium 0.149 mg, natrium 0.149 mg, acidum succinicum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 0.83 ml. Tela cum: alcohol isopropylicus.
Articles (1)
Skyrizi 75 mg, lnjektionslösung in einer Fertigspritze
Fertigspritze
2
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
TEL
|
- | Substance | HNIDK |
|
SOLU
|
75.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLU
|
34.0 MG | Substance | HBESI |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
0.149 MG | Substance | HBESI |
|
SOLU
|
0.149 MG | Substance | HBESI |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
|
SOLU
|
- | Substance | HNIDK |
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 66944
- Drug name
- Skyrizi, lnjektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AC18
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/04/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SKYRIZI sol inj 75 mg/0.83ml ser pré 2 pce
- Description (DE)
- SKYRIZI Inj Lös 75 mg/0.83ml Fertspr 2 Stk
- Market launch
- 18/04/2019
- Narcotic (BTM)
- No